EN
抗体药类似物
Research Grade Tabalumab
All
  • CatalogTD-HV212026
  • ClonalitymAb
  • Application Research Grade Biosimilar
  • SynonymsLY2127399,CAS:1143503-67-6
  • 规格
    1mg
  • 价格
    ¥询价
定制服务咨询

Research Grade Tabalumab


Catalog No. TD-HV212026
Species reactivity Human
Applications Research Grade Biosimilar
Host species Human
Isotype IgG4-kappa
Expression system Mammalian Cells
Clonality Monoclonal
Target BAFF, ZTNF4, BLYS, Tumor necrosis factor ligand superfamily member 13B, Dendritic cell-derived TNF-like molecule, TALL-1, TNF- and APOL-related leukocyte expressed ligand 1, BLyS, B lymphocyte stimulator, TNFSF13B, CD257, TNFSF20, TALL1, B-cell-activating factor
Endotoxin level Please contact the lab for this information.
Purity >95% purity as determined by SDS-PAGE.
Purification Protein A/G, purified from cell culture supernatant.
Accession Q9Y275
Form Liquid
Storage buffer 0.01M PBS,pH7.4.
Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Alternate Names LY2127399,CAS:1143503-67-6
Background Tabalumab (LY2127399) is a human anti-BAFF (B-cell activating factor) monoclonal antibody (IgG4 type) with neutralising activity against membrane bound and soluble BAFF. Tabalumab can be used in studies of autoimmune diseases such as rheumatoid arthritis, renal failure and systemic lupus erythematosus.
Note For research use only. Not for use in clinical or therapeutic applications.

 

TD-HV212026_1.jpg
Bioactivity
 
SEC-HPLC detection for Research Grade Tabalumab.